Comparison of LMWH Versus UFH for Hemorrhage and Hospital Mortality in the Treatment of Acute Massive Pulmonary Thromboembolism After Thrombolytic Treatment Randomized Controlled Parallel Group Study

Ucar E. Y., Akgün M., Araz Ö., Tas H., Kerget B., Meral M., ...Daha Fazla

LUNG, cilt.193, sa.1, ss.121-127, 2015 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 193 Sayı: 1
  • Basım Tarihi: 2015
  • Doi Numarası: 10.1007/s00408-014-9660-z
  • Dergi Adı: LUNG
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.121-127
  • Anahtar Kelimeler: Pulmonary thromboembolism, Thrombolytic treatment, Low molecular weight heparin, Unfractionated heparin, Mortality, MOLECULAR-WEIGHT HEPARIN, UNFRACTIONATED HEPARIN, EMBOLISM, MANAGEMENT, THERAPY, RISK, METAANALYSIS, THROMBOSIS
  • Atatürk Üniversitesi Adresli: Evet

Özet

Current guidelines recommend the use of low molecular weight heparin (LMWH) for most haemodynamically stable patients with pulmonary thromboembolism (PTE), however, it is not clear whether LMWH is preferable to unfractionated heparin (UFH) for the treatment of massive PTE. We aimed to compare the use of LMWH versus UFH after thrombolytic treatment in the management of acute massive PTE for hemorrhage and hospital mortality.